Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional Results available

Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome

ClinicalTrials.gov ID: NCT02544152

Public ClinicalTrials.gov record NCT02544152. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 24, 2026, 1:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Lubiprostone in Adult Subjects With Mixed or Unsubtyped Irritable Bowel Syndrome (IBS-M/IBS-U)

Study identification

NCT ID
NCT02544152
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sucampo Pharma Americas, LLC
Industry
Enrollment
71 participants

Conditions and interventions

Interventions

  • Lubiprostone Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Nov 30, 2016
Completion
Nov 30, 2016
Last update posted
Dec 26, 2019

2015 – 2016

United States locations

U.S. sites
16
U.S. states
9
U.S. cities
16
Facility City State ZIP Site status
E Squared Research, Inc. Huntsville Alabama 35801
Arkansas Gastroenterology North Little Rock Arkansas 72117
GW Research Inc. Chula Vista California 91910
Inland Empire Liver Foundation Rialto California 92377
Prestige Clinical Research Center Miami Florida 33133
Advanced Gastroenterology Associates, LLC Palm Harbor Florida 34684
Meritus Center for Clinical Research Hagerstown Maryland 21742
Mayo Clinic Rochester Minnesota 55905
PMG Research of Charlotte Charlotte North Carolina 28210
PMG Research of Charlotte Concord North Carolina 28025
Cumberland Research Associates, LLC Fayetteville North Carolina 28304
Wake Research Associates, LLC Raleigh North Carolina 27612
Clinical Research Solutions Jackson Tennessee 38305
Houston Endoscopy Research Center Houston Texas 77079
Wellness Clinical Research Associates McKinney Texas 75071
Advanced Clinical Research Associates Plano Texas 75093

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02544152, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 26, 2019 · Synced Jul 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02544152 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →